COMPARISON OF THERAPEUTIC RESULTS BETWEEN TAE REGIMEN AND REGIONAL CHEMOTHERAPY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) IN STAGE III AND IV-A